3 recruiting, 1 completed. 2 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow FSRT: new trials by email Literature Review of FSRT trials Research Report on FSRT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases FSRT, HA-WBRT-SIB, Bevacizumab - Lung Adenocarcinoma, Brain Metastases | Phase 3 | Recruiting | Sun Yat-sen University | 220 | 2026-03-20 | 2026-04-06 |
| FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma Bevacizumab, FSRT, Whole brain radiotherapy - Multiple Brain Metastases in Lung Adenocarcinoma | Phase 3 | Recruiting | Sun Yat-Sen University Cancer Center | 258 | 2025-06-30 | 2025-12-02 |
| Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases SRT, fSRT - Brain Metastases | Not applicable | Recruiting | Haaglanden Medical Centre | 130 | 2022-07-18 | 2024-03-12 |
| Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases Fractionated Stereotactic Radiotherapy, Temozolomide - Brain Metastases | Phase 2 | Completed | Chinese Academy of Medical Sciences | 65 | 2011-10-01 | 2017-06-06 |
Brain Neoplasms (3) · Adenocarcinoma of Lung (1) · Meningeal Carcinomatosis (1)
Chinese Academy of Medical Sciences (1) · Haaglanden Medical Centre (1) · Sun Yat-Sen University Cancer Center (1) · Sun Yat-sen University (1)
China (3) · Netherlands (1)
Jaap D Zindler, MD, PhD (1) · Jianping Xiao (1)
PMID 15254054, PMID 16757720, PMID 16856022, PMID 19801201, PMID 23814264, PMID 25349290, PMID 27458945, PMID 29420112, PMID 30395902, PMID 30996008, PMID 31569068, PMID 32058845, PMID 32347302, PMID 36964529